Global Medical REIT Management
Management criteria checks 2/4
Global Medical REIT's CEO is Jeff Busch, appointed in Aug 2015, has a tenure of 9.25 years. total yearly compensation is $2.18M, comprised of 32.1% salary and 67.9% bonuses, including company stock and options. directly owns 0.065% of the company’s shares, worth €364.15K. The average tenure of the management team and the board of directors is 8.7 years and 8.7 years respectively.
Key information
Jeff Busch
Chief executive officer
US$2.2m
Total compensation
CEO salary percentage | 32.1% |
CEO tenure | 9.3yrs |
CEO ownership | 0.07% |
Management average tenure | 8.7yrs |
Board average tenure | 8.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$1m |
Jun 30 2024 | n/a | n/a | -US$56k |
Mar 31 2024 | n/a | n/a | US$15m |
Dec 31 2023 | US$2m | US$700k | US$15m |
Sep 30 2023 | n/a | n/a | US$16m |
Jun 30 2023 | n/a | n/a | US$21m |
Mar 31 2023 | n/a | n/a | US$11m |
Dec 31 2022 | US$2m | US$650k | US$13m |
Sep 30 2022 | n/a | n/a | US$17m |
Jun 30 2022 | n/a | n/a | US$12m |
Mar 31 2022 | n/a | n/a | US$13m |
Dec 31 2021 | US$2m | US$600k | US$12m |
Sep 30 2021 | n/a | n/a | US$9m |
Jun 30 2021 | n/a | n/a | -US$5m |
Mar 31 2021 | n/a | n/a | -US$7m |
Dec 31 2020 | US$3m | US$298k | -US$8m |
Sep 30 2020 | n/a | n/a | -US$8m |
Jun 30 2020 | n/a | n/a | US$3m |
Mar 31 2020 | n/a | n/a | US$4m |
Dec 31 2019 | US$455k | n/a | US$3m |
Sep 30 2019 | n/a | n/a | US$9m |
Jun 30 2019 | n/a | n/a | US$9m |
Mar 31 2019 | n/a | n/a | US$8m |
Dec 31 2018 | US$396k | n/a | US$8m |
Sep 30 2018 | n/a | n/a | US$440k |
Jun 30 2018 | n/a | n/a | US$535k |
Mar 31 2018 | n/a | n/a | -US$23k |
Dec 31 2017 | US$673k | n/a | -US$2m |
Compensation vs Market: Jeff's total compensation ($USD2.18M) is above average for companies of similar size in the German market ($USD1.05M).
Compensation vs Earnings: Jeff's compensation has increased whilst the company is unprofitable.
CEO
Jeff Busch (64 yo)
9.3yrs
Tenure
US$2,181,100
Compensation
Mr. Jeffrey M. Busch, also known as Jeff, is Director of IMAC Holdings, Inc. from September 19, 2024. Mr. Busch is Chairman of the Board at Theralink Technologies, Inc. (formerly known as OncBioMune Pharma...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman | 9.3yrs | US$2.18m | 0.065% € 364.2k | |
CFO & Treasurer | 7.3yrs | US$1.41m | 0% € 0 | |
Chief Operating Officer | 8.7yrs | US$935.78k | 0.00075% € 4.2k | |
Chief Investment Officer | 9.3yrs | US$1.34m | 0% € 0 | |
General Counsel & Corporate Secretary | 7.5yrs | US$872.70k | 0% € 0 | |
Investor Relations Professional | no data | no data | no data |
8.7yrs
Average Tenure
51yo
Average Age
Experienced Management: 3UN's management team is seasoned and experienced (8.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman | 10.2yrs | US$2.18m | 0.065% € 364.2k | |
Independent Director | 9.3yrs | US$155.71k | 0.012% € 65.6k | |
Lead Independent Director | 9.3yrs | US$183.21k | 0.012% € 64.7k | |
Independent Director | 6.4yrs | US$177.77k | 0% € 0 | |
Independent Director | 6.5yrs | US$203.10k | 0% € 0 | |
Independent Director | 8.7yrs | US$153.48k | 0% € 0 | |
Director | 8.7yrs | no data | 0% € 0 |
8.7yrs
Average Tenure
65yo
Average Age
Experienced Board: 3UN's board of directors are considered experienced (8.7 years average tenure).